Alosetron (Lotronex) For Treatment of Irritable Bowel Syndrome
Alosetron hydrochloride (Lotronex - Glaxo Welcome), a selective serotonin receptor antagonist, has received FDA approval for treatment of irritable bowel syndrome (IBS) in women whose primary bowel symptom is diarrhea....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Alosetron (Lotronex) For Treatment of Irritable Bowel Syndrome
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1081
Article Code: 1081a
Date: June 26, 2000
Volume: 42
Pages: 53-54
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1081
Article Code: 1081a
Date: June 26, 2000
Volume: 42
Pages: 53-54
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)